Clinical overview of Deferasirox Ion Chelation Theropy

Registration ID: IJNRD_194499

Published ID: IJNRD2305243

DOI: Click Here to Get

Divya Diliprao Deshmukh , Aarti Nivas Patil , Rushikesh Janik Divate

Deferasirox, iron overload, thalassemia, sickle cell disease, and myelodysplastic syndrome are some of the terms that may be used.

Deferasirox, an oral iron chelator that is given once daily, is often used in the treatment of people with transfusional hemosiderosis. In several Phase II trials and their respective extension studies, as well as a Phase III trial, the effectiveness and safety of this novel agent in transfusion-dependent patients with -thalassemia, sickle cell disease, and bone marrow failure syndromes, including myelodysplastic syndrome and aplastic anemia, have been established. According to evidence from several clinical trials, a deferasirox dose of 20 mg/kg/day stabilises serum ferritin levels and liver iron concentration, while a dose of 30-40 mg/kg/day reduces these values and causes negative iron balance in red cell transfusion-dependent patients with iron overload. In multiple important clinical trials, deferasirox was well tolerated, with the most common side effects being gastrointestinal issues, skin rashes, non-progressive blood creatinine rises, and elevations in liver enzyme levels. Longer-term extension studies have also demonstrated the efficacy and safety of deferasirox. Patients taking deferasirox therapy must be routinely observed to ensure quick treatment for any side effects that may develop with long-term medication.

Published Paper   E-Certificate

Divya Diliprao Deshmukh, Aarti Nivas Patil, & Rushikesh Janik Divate (May-2023). Clinical overview of Deferasirox Ion Chelation Theropy. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(5), c316-c325. https://ijnrd.org/papers/IJNRD2305243.pdf

Volume 8 Issue 5, May-2023

Pages : c316-c325

Paper Reg. ID: IJNRD_194499

Published Paper Id: IJNRD2305243

Downloads: 000121977

Research Area: Pharmacy

Country: Jalna, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2305243.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2305243

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details